Cupping vs UVB: Comparable Psoriasis Outcomes? - Top-Institutions - MDSpire

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.

  • By

  • Meg Barbor

  • April 9, 2026

  • 2 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    National Psoriasis Foundation
    National Psoriasis Foundation

    Portland, Oregon

    Key Differentiators

    • Dermatology
    • Psoriasis Research
    • Phototherapy

  • #2

    University of California, San Francisco (UCSF) Department of Dermatology
    University of California, San Francisco (UCSF) Department of Dermatology

    San Francisco, California

    Key Differentiators

    • Dermatology
    • Psoriasis
    • Phototherapy
    • Integrative Medicine

  • #3

    Mayo Clinic Department of Dermatology
    Mayo Clinic Department of Dermatology

    Rochester, Minnesota

    Key Differentiators

    • Dermatology
    • Psoriasis
    • Phototherapy

  • #4

    Harvard Medical School, Massachusetts General Hospital Dermatology
    Harvard Medical School, Massachusetts General Hospital Dermatology

    Boston, Massachusetts

    Key Differentiators

    • Dermatology
    • Psoriasis
    • Phototherapy
    • Integrative Medicine

  • #5

    Peking University First Hospital, Department of Dermatology
    Peking University First Hospital, Department of Dermatology

    Beijing, Beijing

    Key Differentiators

    • Dermatology
    • Psoriasis
    • Traditional Chinese Medicine

Original Source(s)

Cupping vs UVB: Comparable Psoriasis Outcomes?

  • by Meg Barbor

  • April 9, 2026

Related Content

Pediatric Dermatology Clinic now accepting referrals for complex cases

This program provides subspecialty expertise in the diagnosis and management of complex pediatric dermatologic diseases.

  • by

  • May 14, 2026

  • 1 min
Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse

Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis